Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A gene transcription signature of the Akt/mTOR pathway in clinical breast tumors

8 Jan 2007

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Lung Cancer Treatments and Mutations
Share to PI3K/AKT/mTOR signaling in cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 17213801
DOI: 10.1038/sj.onc.1210245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A gene transcription signature of the Akt/mTOR pathway in clinical breast tumorsPMID 17213801Read ↗

Establishment and validation of a novel autophagy-related gene signature for patients with breast cancerSemantic proximity Read ↗

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trialsSemantic proximity Read ↗

Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTORSemantic proximity Read ↗

pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activationSemantic proximity Read ↗

Activated Akt expression in breast cancer: Correlation with p53, Hdm2 and patient outcomeSemantic proximity Read ↗

Differential gene expression and AKT targeting in triple negative breast cancerSemantic proximity Read ↗

The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer-A Preliminary Study.Semantic proximity Read ↗

Biomarkers and patient selection for PI3K/Akt/mTOR targeted therapies: current status and future directions.Semantic proximity Read ↗

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical ChallengesSemantic proximity Read ↗

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted TherapeuticsSemantic proximity Read ↗

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteinsSemantic proximity Read ↗

Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an updateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.